- Acronym:
- Gliomed
- Logotype:
-
- Duration:
- 01.04.2017 - 31.12.2020
- Aim:
- Gliomas are incurable despite progress in surgery, radiotherapy and chemotherapy. Specific diagnosis of the type of glioma, early detection of molecular progression, characterization of critical mutations or epigenetic characteristics in individual patient give hope to improve treatment results. We developed a comprehensive diagnostic test based on analysis of the material obtained from the tumor via surgery or biopsy. This led to a liquid biopsy-type method based on tumor cfDNA in blood, which is a quick and minimally invasive alternative to biopsy. The results contribute to better understanding of glioma biology and lead to identification of new molecular biomarkers. The proposed diagnostic test improves treatment results by therapy individualization and liquid biopsy improves safety, comfort and enable to monitor disease course and treatment in a new way.
- Contact:
- Tomasz Gubała, e-mail: cyfronet (at) cyfronet.pl, phone: (+48 12) 632 33 55 ext. 704
Completed